The Evolutionary Question: Why Does Biology Produce Consciousness-Altering Tryptamines?

Language: en

The Question That Neuroscience Cannot Answer

There is a question at the heart of tryptamine biology that haunts every honest researcher who encounters it. It is not a technical question about receptors or signaling cascades. It is a question about purpose — the kind of question that science is supposed to be able to answer and, in this case, cannot.

The question: Why does biology produce molecules that alter consciousness?

Not just serotonin, whose mood-regulating functions are explicable in evolutionary terms. Not just melatonin, whose circadian-regulatory functions are adaptive. But DMT. Psilocybin. 5-MeO-DMT. Bufotenine. The psychedelic tryptamines — molecules that, when they reach the brain in sufficient concentrations, dissolve the ego, generate encounters with non-human intelligences, reveal geometric architectures of infinite complexity, and permanently alter the user’s understanding of the nature of reality.

Why does the human brain produce DMT at neurotransmitter-level concentrations? Why do over 200 species of mushrooms produce psilocybin? Why does the Sonoran Desert toad produce 5-MeO-DMT? Why do hundreds of plant species across every continent produce DMT, harmine, and other consciousness-altering tryptamines?

The standard evolutionary explanation — that these molecules are defensive chemicals, produced by plants and fungi to deter herbivores — is partially true for some cases but fails catastrophically as a general explanation. Psilocybin does not effectively deter the insects that are the primary herbivores of Psilocybe mushrooms. DMT is produced by the human brain itself, where it has no defensive function. 5-MeO-DMT is produced in toad skin glands alongside genuinely toxic compounds, but its effects in humans are not toxic — they are consciousness-expanding.

And the deeper problem: even if we explain why plants and fungi produce these molecules, we still have not explained why the human brain has receptors that respond to them with such specific and dramatic effects. The 5-HT2A receptor did not evolve to be activated by psilocybin mushrooms. It evolved to be activated by serotonin. But when psilocybin activates it, the result is not a pathological response (as you would expect if the receptor were being “hijacked” by a foreign compound). The result is a coherent, structured, reproducible, and often profoundly meaningful altered state of consciousness — a state that a growing body of clinical evidence shows is therapeutic, transformative, and valued as among the most important experiences of people’s lives.

This is the mystery. Not that psychedelic molecules exist, but that the brain has a built-in response to them that looks designed rather than accidental.

The Defensive Chemical Hypothesis and Its Failures

The most commonly cited evolutionary explanation for psychedelic tryptamines in plants and fungi is the defensive chemical hypothesis: these molecules evolved to deter herbivory. Animals that eat the plant or fungus experience disorientation, nausea, or aversion, and learn to avoid the species in the future.

This hypothesis works well for genuinely toxic compounds — strychnine, ricin, digitalis. Animals that consume these die or become seriously ill, providing strong selective pressure against consumption.

But it fails for psychedelic tryptamines in several ways:

The dose problem. Psychedelic tryptamines, at doses consumed by herbivores, do not cause death or serious physical harm. Psilocybin’s LD50 (the dose required to kill 50% of test subjects) in rodents is approximately 280 mg/kg — thousands of times higher than the psychoactive dose. A deer or a slug eating a Psilocybe mushroom would not be harmed or deterred.

The specificity problem. If psilocybin evolved as a herbivore deterrent, it should produce a generic aversive response — pain, nausea, disorientation. Instead, it produces a highly specific and structured alteration of consciousness — with consistent features (ego dissolution, visual hallucinations, mystical experience) across species, doses, and contexts. This specificity suggests a function more nuanced than simple deterrence.

The distribution problem. Psilocybin-producing mushrooms grow on decomposing organic matter and dung. Their primary “herbivores” are insects. But psilocybin’s effects on insects are poorly studied, and there is no evidence that it effectively deters the insects that actually consume the mushrooms.

The human brain problem. DMT is produced endogenously in the human brain. It has no defensive function there. Its production is not a response to herbivory — it is a baseline neurochemical process occurring in the same neurons that produce serotonin.

The defensive chemical hypothesis may explain some aspect of psilocybin’s presence in mushrooms, but it cannot explain why the brain has receptors that respond to these compounds with such coherent, structured, and therapeutically beneficial effects.

The Symbiosis Hypothesis: Tryptamines as Interspecies Communication

An alternative hypothesis — more speculative but more explanatory — is that psychedelic tryptamines function as interspecies communication molecules.

The biological world is saturated with chemical communication. Plants communicate with pollinators through volatile organic compounds. Trees communicate with each other through mycorrhizal fungal networks (the “wood wide web” documented by Suzanne Simard). Bacteria communicate through quorum sensing molecules. Chemical communication is the oldest and most universal form of biological information exchange.

The symbiosis hypothesis proposes that tryptamines are part of this communication system — that they evolved not as weapons but as signals, mediating mutualistic relationships between species:

Plant-human mutualism. The psychedelic plants that have been integrated into human ceremonial life — ayahuasca, peyote, psilocybin mushrooms, iboga — are all species that benefit from human cultivation, propagation, and protection. Psilocybe cubensis grows on cattle dung and has spread globally following the spread of human cattle-herding. Banisteriopsis caapi is cultivated and propagated by Amazonian peoples. Tabernanthe iboga is protected by the Bwiti community. The peyote cactus is protected by the Native American Church.

If the psychedelic experience motivates humans to protect and propagate the producing species, then the production of psychedelic compounds confers a direct fitness advantage on the species — through mutualism with the most powerful ecological force on Earth (human culture).

Fungal-neuronal convergence. The mycelial networks of fungi and the neural networks of brains share remarkable structural similarities — branching, interconnected architectures that process information through chemical signaling across distributed nodes. Paul Stamets has argued that mycelial networks are a form of distributed intelligence, solving optimization problems (nutrient transport, pathogen defense, resource allocation) that parallel the problems solved by neural networks.

If both systems use tryptamine-based signaling (fungi produce psilocybin; neurons produce serotonin and DMT), the convergence may not be accidental. It may indicate a deep evolutionary kinship between fungal and neural information processing — a shared biochemical language rooted in the tryptamine scaffold.

The Neuroplasticity Hypothesis: Tryptamines as Brain Maintenance

A more conservative hypothesis — compatible with materialist neuroscience — is that endogenous tryptamines (particularly DMT) serve a neuroplastic function: they promote the growth, maintenance, and repair of neural circuits.

Evidence supporting this hypothesis:

Psychedelic-induced neuroplasticity. Ly et al. (2018, Cell Reports) demonstrated that psychedelic tryptamines (DMT, psilocin, LSD) promote dendritic growth and synaptogenesis in cortical neurons — effects comparable to BDNF. If endogenous DMT, produced at low tonic levels, serves a similar function, it could be understood as a neuroplasticity maintenance signal — a trophic factor that keeps cortical neurons healthy and flexible.

Sigma-1 receptor activation. DMT’s activity at sigma-1 receptors — which are involved in cellular stress responses, calcium signaling, and endoplasmic reticulum function — suggests a role in cellular maintenance and repair. Sigma-1 receptor activation is neuroprotective under conditions of oxidative stress, ischemia, and excitotoxicity.

The cardiac arrest finding. Borjigin’s observation that DMT levels increase during cardiac arrest is consistent with a neuroprotective function — the brain may release DMT as a last-ditch effort to protect neurons during the metabolic catastrophe of dying.

This hypothesis is attractive because it is testable and does not require metaphysical commitments. But it fails to explain why the neuroplasticity-promoting compound also happens to produce the most profound altered states of consciousness known — states that include encounters with intelligent entities, perception of cosmic unity, and permanent reduction in the fear of death.

If DMT is “just” a neuroplasticity factor, why does it produce mystical experiences? Aspirin is an anti-inflammatory, and it does not produce visions of God.

The Consciousness Antenna Hypothesis

The most radical hypothesis — consistent with the theoretical frameworks of Bohm, Jung, and Peat, and with the universal testimony of shamanic cultures — is that tryptamines function as consciousness antennae, tuning the brain’s receiver to different frequency bands of a universal information field.

In this hypothesis:

Consciousness is not generated by the brain. It is received by the brain. The brain functions as a transceiver — a device that both receives and transmits consciousness, analogous to a radio that receives and transmits electromagnetic signals. The brain does not produce the music. It tunes into it.

Tryptamines are the tuning molecules. Serotonin tunes the brain to the “survival frequency” — the bandwidth of information processing optimized for navigating the physical world, maintaining social relationships, and ensuring reproductive success. Melatonin tunes to the “dream frequency” — the bandwidth accessed during sleep, where memory consolidation, emotional processing, and creative problem-solving occur. DMT and psilocin tune to the “transpersonal frequency” — the bandwidth that accesses the deeper levels of the information field, where individual consciousness merges with universal consciousness, where entity encounters occur, and where the fundamental nature of reality becomes directly perceivable.

The 5-HT2A receptor is the antenna. The specific location of 5-HT2A receptors on cortical pyramidal neurons — the output neurons of the cortex, the neurons most involved in the construction of conscious experience — makes them the ideal candidates for the “antenna” function. When tryptamines activate these receptors, they change the brain’s tuning — not by adding noise or distortion, but by shifting the frequency band to which the brain is sensitive.

Evolution built the antenna for a reason. If the brain is a consciousness transceiver, and tryptamines are the tuning molecules, then evolution built this system because access to transpersonal information confers survival advantages — not immediately obvious, but real. Shamanic cultures that maintained access to the transpersonal bandwidth (through psychedelic plants, drumming, fasting, and other techniques) were better at prediction, healing, social cohesion, and environmental adaptation than cultures that did not.

The Shamanic Answer: The Spirit World IS Real

Every indigenous culture that works with psychedelic tryptamines has the same explanation: the molecules open the door to the spirit world, and the spirit world is real.

This is not a metaphor. The Shipibo curandera who says “ayahuasca showed me which plants to combine” is not speaking figuratively. The Mazatec curandera who says “the mushrooms told me the diagnosis” is making a clinical claim. The Bwiti initiate who says “I met my dead grandfather and he gave me guidance” is reporting an encounter.

Western science dismisses these reports as hallucination — the brain generating convincing but false experiences from its own neural activity. This dismissal rests on an assumption: that consciousness is generated by the brain and that anything experienced during an altered brain state is, by definition, a product of the brain rather than a perception of an external reality.

But this assumption is exactly what the tryptamine evidence calls into question. If the brain produces DMT at neurotransmitter-level concentrations, and if DMT produces consistent, structured, replicable experiences of encountering intelligent non-human presences — experiences that are therapeutic, transformative, and valued as among the most meaningful of people’s lives — then the assumption that these experiences are “just” hallucinations is not a conclusion drawn from evidence. It is a prior philosophical commitment imposed on evidence that does not support it.

The honest position is agnosticism: we do not know whether the DMT space is real or hallucinated. We do not have the theoretical framework to distinguish between these possibilities. We do not have a theory of consciousness that can explain why the brain produces a molecule that generates encounters with autonomous intelligences.

What we do have is the molecules. They are real. They are in your brain. They are in the mushrooms. They are in the vine. They are in the toad. They are everywhere in biology.

And they are all built on the same scaffold — the indole ring plus ethylamine chain — that has been modulating consciousness since before there were brains to modulate.

The Engineering Summary: A System That Demands Explanation

The tryptamine consciousness system, viewed as an engineering problem, has these features:

1. A single molecular template (the tryptamine scaffold) that generates the full spectrum of consciousness states from baseline mood to cosmic dissolution.

2. An endogenous production system (the biosynthetic pathway from tryptophan through serotonin, melatonin, and DMT) that operates in the brain and gut without any external input.

3. A precision receptor system (14 serotonin receptor subtypes, with the 5-HT2A receptor functioning as the “consciousness expansion” receptor) that transduces the molecular signal into specific neural and experiential states.

4. Exogenous keys (psilocybin, DMT, 5-MeO-DMT, mescaline) produced by organisms across the biological kingdom — plants, fungi, amphibians, mammals — all fitting the same endogenous locks.

5. Therapeutic effects (antidepressant, anti-addictive, anxiolytic, pro-social, neuroplastic) that emerge reliably from the activation of this system, suggesting that the system is not being hijacked but is being used for its intended purpose.

6. Experiential effects (mystical experience, entity encounter, ego dissolution, cosmic unity) that are consistent across cultures, individuals, historical periods, and substances — suggesting that the system is detecting something real, not generating random noise.

This is not a system that evolved by accident. This is not a system whose only function is defense against herbivores. This is not a system adequately explained by “neural noise” or “pattern recognition error.”

This is a system that demands an explanation. And the explanation, whatever it turns out to be, will transform our understanding of consciousness, evolution, and the nature of reality.

The tryptamines are asking a question. The question is: What are we? The answer is encoded in the molecules themselves — in the indole ring that spans the kingdom of life, in the serotonin that makes you feel, in the melatonin that makes you dream, and in the DMT that shows you what dreaming is made of.

The question is whether we have the courage to look at the answer.